Ziment is one of the largest international full-service, custom marketing research organizations in the world specializing in the healthcare and pharmaceutical industries.

We've been around for more than 30 years, providing full-service marketing research worldwide with an emphasis on insight and practical solutions to complex problems. Our experience in virtually all therapeutic categories and types of healthcare professionals and patients across the globe has allowed us to build a long and distinguished list of clients, including just about all of the world's most prominent pharmaceutical companies.

What makes us different from the competition? The difference is the way we utilize our resources to bring to bear a team of professionals with unmatched expertise, professionalism and global reach. We fuse industry-leading intellectual capital, highly talented staff, and global resources to provide our clients with breakthrough research-based solutions to some of their most challenging marketing issues.

Clients know that they can trust the way we put all of our global resources together to deliver creative business insight and direction. The research we conduct points to practical and meaningful results that make sense and can actually be implemented.

Ziment has its own staff in many cities across the US, including New York, home of our global headquarters. We also have staff at our European headquarters in the UK as well as in France, Germany and Spain. Our trained researchers are where you are to make sure you make the best decisions about your work with the right cultural imperative, in the right way for each market.

Our online panel has now 200,000 physicians and healthcare professionals in the US and Europe with very high cooperation/response rates; therefore we can provide the largest sample sizes in the industry. And our patient panel provides access to over 350,000 patients in the US and Europe, with close to 100 different chronic illnesses. This makes it easy to find low incidence patient groups while allowing patients to speak openly about their disease.